AdaptHealth (NASDAQ:AHCO) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
1
0
0
0
Last 30D
1
0
0
0
0
1M Ago
0
0
0
0
0
2M Ago
0
0
0
0
0
3M Ago
2
1
0
0
0
Analysts have recently evaluated AdaptHealth and provided 12-month price targets. The average target is $13.0, accompanied by a high estimate of $13.00 and a low estimate of $13.00. Surpassing the previous average price target of $11.00, the current average has increased by 18.18%.
Decoding Analyst Ratings: A Detailed Look
The standing of AdaptHealth among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
David Macdonald
Truist Securities
Maintains
Buy
$13.00
$13.00
Ben Hendrix
RBC Capital
Maintains
Outperform
$13.00
-
Whit Mayo
UBS
Raises
Buy
$13.00
$9.00
David Macdonald
Truist Securities
Raises
Buy
$13.00
$11.00
Key Insights:
Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AdaptHealth. This information offers a snapshot of how analysts perceive ...Full story available on Benzinga.com
Benzinga
